Editorial ILD in rheumatic disease: navigating complexity + + +... The Lancet Rheumatology

Editorial ILD in rheumatic disease: navigating complexity https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00228-0/fulltext?dgcid=raven_jbs_etoc_email Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00060-8/abstract?dgcid=raven_jbs_etoc_feature_lanrhe Sep 2025 Volume 7Number 9e591-e658 https://www.thelancet.com/journals/lanrhe/issue/vol7no9/PIIS2665-9913(25)X0009-6